COMPANY PROFILE

Biomodex

Explore full profile

Fabricate life-like organs that can be used for medical training and pre-operative planning

Paris, FranceFounded 2015Health Tech & Medtech

Valuation $50–100M Last recorded · 2018

Revenue <$1M Latest reported FY

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

At a glance

Status: Closed
Founded: 2015
Headquarters: Paris, France
Employees: 3
Open positions: None listed
Dealroom signal: 0.0/100
Industry: Health
Sub-industry: Medical Devices
Sector: Health Tech & Medtech, Training, Surgery, Medical Education, Surgical Equipment, Tech for Hospitals and Clinics, Tech for Medical Professionals
Technology: Hardware, 3D Technology, Deep Tech
Business model: Manufacturing, SaaS
Client focus: b2b
Links: Website X

News, research, reports and resources connected to this company by Dealroom

4 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES A✓Equity / VC	Jun 2018	$15M	$60M	Eurazeo · LBO France · InnovAllianz · Inserm Transfert Initiative	↗
EARLY VC✓Equity / VC	Apr 2016	$3.6M	$14M	Kima Ventures · Inserm Transfert Initiative · Innovation Capital	—

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Biomodex website traffic

Latest recorded traffic for Biomodex is 650 monthly website visits, up 8.3% over the last three months. Biomodex's team grew 0% over the past year.

Latest monthly visits650 3-month web change+8.3% 1-year team growth0%

Monthly website visitsFeb 2016–May 2025

Summary metrics are public; monthly history is available with a demoCompare with peers →

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
EReCential RoboticsDesigned the first all-in-one surgical platform combining 2D Fluoroscopy, 3D Imaging, and real-time navigation	Gières, France	Acquired	72	$126M	$194M
SUSurgeInnovative fingerprinting of the immune system with AI to holistically improve the perioperative standard-of-care	Paris, France	Operational
QSQuantum SurgicalDemocratizes minimally invasive cancer treatment through preplanning, advanced robotic assistance, and tumor ablation confirmation	Montpellier, France	Operational
RORobocathInnovative solutions for the treatment of cardiovascular diseases	Rouen, France	Acquired
RERebrAInRebrAIn offers accurate targeting technology for Deep Brain Stimulation thanks to an algorithm based on Artificial Intelligence	Pessac, France	Operational
GRGanymed RoboticsGanymed retools orthopaedics with robotics. Their product is a compact, ergonomic, and cost-effective joint-replacement device. The robot's intelligence and perception are driven by computer vision	Paris, France	Operational
THTherapixelSoftware company specialized in artificial intelligence for medical image analytics	Paris, France	Operational
SRSpinEM RoboticsDeveloping a surgical robot for minimally invasive spinal surgery based on an innovative tracking system	Saint-Martin-d'Hères, France	Operational